ArticleArchives of medical sciences. Atherosclerotic diseases2025

Omecamtiv mecarbil, a cardiac myosin activator with potential efficacy in heart failure.

Mohammed Kallash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.